共查询到20条相似文献,搜索用时 175 毫秒
1.
背景:纳米羟基磷灰石/聚己内酯是一种具有优良生物相容性和生物活性的典型生物复合材料。
目的:分析纳米羟基磷灰石/聚己内酯电纺薄膜作为组织工程骨支架的可行性。
方法:采用静电纺丝技术制备纳米羟基磷灰石/聚己内酯电纺薄膜,将其与第3代SD大鼠骨髓间充质干细胞复合培养,在地塞米松、β-磷酸甘油钠、维生素C成骨诱导剂诱导下,诱导骨髓间充质干细胞向成骨细胞转化。
结果与结论:纳米羟基磷灰石/聚己内酯支架具有合适的微孔结构,且孔道相互贯通。①倒置显微镜观察:复合培养 7 d后细胞大部分为梭形,细胞开始分裂;14 d后,细胞生长比较旺盛,数量明显增多,细胞分泌基质并黏附于支架上。②扫描电镜观察:复合培养7 d后大量细胞位于支架孔隙内生长,增殖良好,细胞大多呈梭形,双极突起,形态较佳,呈立体状生长,并分泌基质,有纤维连接蛋白生成。表明纳米羟基磷灰石/聚己内酯支架具有良好的生物相容性,是骨组织工程的良好载体。 相似文献
2.
《中国组织工程研究》2014,(8)
背景:研究发现将聚丙交酯、纳米羟基磷灰石或聚丙交酯两两复合后可在一定程度上改善支架的机械性能、生物相容性和对细胞的成骨诱导分化,但离理想的骨组织工程支架材料尚有一定的距离。目的:对比不同配比纳米羟基磷灰石/壳聚糖/聚丙交酯支架的体外生物相容性及生物活性。方法:采用粒子沥滤法制备纳米羟基磷灰石、壳聚糖、聚丙交酯的质量比分别为10∶10∶80、10∶20∶70、20∶10∶70的复合支架。将3组复合支架与人骨髓间充质干细胞进行体外复合培养,绘制细胞在支架上的生长曲线,以RT-PCR检测细胞碱性磷酸酶活性和骨钙素的表达。结果与结论:配比为20∶10∶70复合支架的细胞黏附率明显高于其他两复合支架组(P0.01),并且复合培养9-27 d的细胞碱性磷酸酶活性、复合培养15-27 d的骨钙素表达明显高于其他两复合支架组(P0.01),3组细胞的增殖趋势相似。说明配比为20∶10∶70的纳米羟基磷灰石/壳聚糖/聚丙交酯支架具有良好的生物相容性及骨诱导活性。 相似文献
3.
背景:目前骨组织工程常用的支架材料主要有无机材料、有机高分子材料及天然衍生材料等,上述材料各有优缺点,为了充分发挥各类材料的优势,弥补其不足,目前多采用联合材料制备复合支架。
目的:制备新型仿生支架材料骨形态发生蛋白7多肽/壳聚糖/纳米羟基磷灰石/胶原,并观察其对骨髓间充质干细胞增殖、黏附及分化的影响。
方法:制备壳聚糖/纳米羟基磷灰石/胶原复合支架材料,扫描电镜观察支架材料表面微观形貌;采用真空吸附法将骨形态发生蛋白7多肽与支架材料复合,高效液相色谱仪检测骨形态发生蛋白7多肽在体外的释放规律;将骨髓间充质干细胞接种到复合骨形态发生蛋白7多肽的仿生支架材料上,以未复合多肽的支架材料作为对照,检测支架材料表面细胞增殖、黏附率、生长形态及碱性磷酸酶活性。
结果与结论:壳聚糖/纳米羟基磷灰石/胶原支架材料呈多孔状,孔径10~100 µm;骨形态发生蛋白7多肽可以从支架材料中缓慢释出;在复合多肽的仿生支架材料表面,骨髓间充质干细胞的黏附及向成骨细胞方向分化能力均明显强于对照组(P < 0.05),而增殖能力与对照组差异无显著性意义(P > 0.05)。说明新型仿生支架材料骨形态发生蛋白7多肽/壳聚糖/纳米羟基磷灰石/胶原是一种理想的骨组织工程支架材料,具有良好的细胞相容性。 相似文献
4.
《中国组织工程研究》2010,(47)
背景:最近胶原蛋白作为细胞体外三维立体支架材料被大量用于组织工程,但胶原蛋白支架材料机械强度低,很难承受较大外力,为此将胶原蛋白与羟基磷灰石制成复合支架材料,探索复合支架的生物相容性和生物活性。目的:验证大鼠骨髓间充质干细胞在羟基磷灰石/胶原蛋白复合支架上的增殖与分化情况。方法:贴壁法分离SD大鼠骨髓间充质干细胞,分别在平板、胶原支架、羟基磷灰石/胶原蛋白复合支架上,观察3种条件下细胞的生长状况,四甲基偶氮唑盐法检测其增殖情况。培养14,21d后,考察细胞碱性磷酸酶活性及胶原蛋白分泌量。结果与结论:发现骨髓间充质干细胞在羟基磷灰石/胶原蛋白复合支架上铺展良好,其增殖率显著高于纯胶原蛋白支架上培养的细胞,并高于平板培养细胞。骨髓间充质干细胞在羟基磷灰石/胶原蛋白复合支架上的碱性磷酸酶活性及胶原蛋白分泌量明显高于纯胶原蛋白支架,高于平板培养。结果提示,羟基磷灰石/胶原蛋白复合材料能促进骨髓间充质干细胞的增殖和分化,并诱导骨髓间充质干细胞向成骨细胞分化。 相似文献
5.
背景:人工合成的纳米羟基磷灰石具有良好的生物活性和相容性,植入体内后能在短时间内与体内的软硬组织形成紧密结合,因此成为广泛应用的骨组织工程材料。
目的:观察豚鼠骨髓间充质干细胞与纳米羟基磷灰石复合多孔陶瓷材料体外复合培养的结合程度,并分析其构建组织工程人工听骨的可行性。
方法:采用细胞差速贴壁法分离培养豚鼠骨髓间充质干细胞,使用流式细胞仪检测CD29、CD45、CD44进行间充质干细胞表面标记物鉴定,并检测其骨细胞分化能力。将骨髓间充质干细胞与纳米羟基磷灰石复合多孔陶瓷共培养1,3,5,7,10 d,电镜观察骨髓间充质干细胞与此种支架材料的复合情况。
结果与结论:培养3 d后,可见大量骨髓间充质干细胞贴附在材料表层,并且形态稳定,生长旺盛,增殖力强,具有极佳的延伸性;培养5 d后可见材料表面已全部覆盖骨髓间充质干细胞,细胞结合紧密,细胞表面可见大量分泌颗粒,胞体明显增大,边缘完整,呈纤维样伸长;7 d后细胞逐渐从材料表面脱落,仍附在材料表面的细胞出现“星形”改变,“伪足”增多;10 d后细胞呈片状脱落。说明纳米羟基磷灰石材料保持了它良好的生物相容性,利于细胞黏附、增殖,可结合大量的骨髓间充质干细胞,用于构建组织工程人工听骨。 相似文献
6.
背景:纳米羟基磷灰石/聚酰胺66材料有利于成骨细胞的长入和新生骨的形成、且抗弯强度、抗压强度等各项参数与正常骨组织的力学性能相接近,能满足实验动物硬组织修复的要求。
目的:分析成骨诱导后人脐带间充质干细胞与纳米羟基磷灰石/聚酰胺66复合支架的生物相容性。
方法:体外培养人脐带间充质干细胞,纯化增殖,成骨诱导。取成骨诱导后的第3代人脐带间充质干细胞接种于纳米羟基磷灰石/聚酰胺66支架材料上,观察细胞的生长、增殖情况及材料细胞毒性。
结果与结论:成骨诱导后人脐带间充质干细胞在复合支架上生长分化良好,增殖活性不受材料影响。成骨诱导14 d内,可见碱性磷酸酶活性随着培养时间延长而逐渐增高。MTT法检测细胞无毒性。扫描电镜观察,1 d后可见细胞在支架表面附着生长;7 d后可见细胞在材料上生长良好,材料空隙有大量充填。说明纳米羟基磷灰石/聚酰胺66支架可作为骨组织工程中人脐带间充质干细胞的细胞载体,具有良好的生物相容性,能满足骨组织工程的需要。关键词:羟基磷灰石/聚酰胺66;人脐带间充质干细胞;细胞培养;骨组织工程;支架;生物相容性
缩略语注释:nHA/PA66:nano-hydroxyapatite crystals and pnolyamide 66,羟基磷灰石/聚酰胺66;hUCMSCs:human umbilical cord mesenchymal stem cells,人脐带间充质干细胞
doi:10.3969/j.issn.1673-8225.2012.16.019 相似文献
7.
《中国组织工程研究》2014,(6)
背景:中药淫羊藿一直以来被用于骨质疏松的治疗和骨缺损的修复。目的:探讨淫羊藿对骨髓间充质干细胞成骨性分化的影响。方法:应用数据库文献检索的方法获取淫羊藿对骨髓间充质干细胞成骨性分化影响研究的文献,对符合研究标准的文献进行深入的分析。通过检测淫羊藿诱导骨髓间充质干细胞成骨性分化过程中碱性磷酸酶、骨钙素、骨桥蛋白、转化生长因子β、骨形态发生蛋白、骨钙素、骨涎蛋白等,了解淫羊藿对骨髓间充质干细胞的增殖和成骨分化的机制。结果与结论:淫羊藿对骨髓间充质干细胞的影响呈剂量依赖性,在诱导培养的早期淫羊藿苷可以提高细胞的磷酸酶活性,在诱导培养的晚期增加细胞钙化结节数,促进骨钙素分泌量,显著提高转化生长因子β1、骨形成蛋白2、胰岛样生长因子1、骨桥蛋白和骨涎蛋白等的表达水平。淫羊藿对骨髓间充质干细胞的增殖和成骨性分化有促进作用,可作为一种良好的骨诱导活性因子。 相似文献
8.
《中国组织工程研究》2010,(38)
背景:随着组织工程和基因工程技术迅速发展,基因增强的组织工程骨为临床治疗骨缺损带来美好的前景。目的:观察经腺病毒介导的人骨形态发生蛋白2表达载体(Ad-BMP-2)转染后的兔骨髓间充质干细胞在纳米羟基磷灰石植骨材料上的黏附、增殖及骨形态发生蛋白2的表达情况。方法:用Ad-BMP-2转染兔骨髓间充质干细胞,免疫组化、蛋白印迹法检测转染后细胞内骨形态发生蛋白2的表达情况。将转染48h的细胞均匀接种到纳米羟基磷灰石植骨材料上,扫描电镜观察细胞黏附状况,并采用MTT比色法测定骨髓间充质干细胞的增殖情况;消化收集黏附植骨材料上第3,5,7天的细胞,蛋白印迹检测黏附材料上细胞骨形态发生蛋白2的表达。结果与结论:转染后,骨髓间充质干细胞内骨形态发生蛋白2有高表达;扫描电镜见转染细胞在纳米羟基磷灰石材料孔隙周围及孔隙内黏附生长良好并大量增殖,MTT分析结果显示,纳米羟基磷灰石对骨髓间充质干细胞的体外增殖无抑制作用,复合后骨形态发生蛋白2有较高表达。结果表明经Ad-BMP-2转染后的骨髓间充质干细胞与纳米羟基磷灰石植骨材料生物相容性好,细胞在材料上能稳定长效地分泌骨形态发生蛋白2。 相似文献
9.
背景:成骨诱导后的脂肪干细胞与可降解丝素蛋白/羟基磷灰石支架复合,可望研制出一种具有良好生物相容性及成骨性能的新型骨融合材料。
目的:探讨丝素蛋白/羟基磷灰石支架对成骨诱导脂肪干细胞增殖活性及成骨性能的影响。
方法:获取大鼠脂肪干细胞后体外贴壁培养、扩增,将第3代细胞用条件培养液进行成骨方向的定向诱导培养、扩增,然后接种到预湿的丝素蛋白/羟基磷灰石材料上作为实验组,以相同条件下置入盖玻片和脂肪干细胞培养作为对照组。倒置相差显微镜观察细胞在材料中的生长情况,MTT法检测材料对细胞增殖活性的影响,碱性磷酸酶活性测定评价其成骨能力。
结果与结论:成骨诱导后的脂肪干细胞在丝素蛋白/羟基磷灰石材料上能够良好地黏附和增殖。实验组和对照组细胞增殖活性及碱性磷酸酶活性比较,差异无显著性意义(P > 0.05),证实脂肪干细胞活性及成骨性能不受材料影响,说明丝素蛋白/羟基磷灰石复合材料具有良好的细胞相容性。
中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程 相似文献
10.
背景:前期实验采用仿生学原理制备了可注射性纳米羟基磷灰石/壳聚糖/半水硫酸钙复合材料,但其与骨髓间充质干细胞的生物相容性还不十分清楚。目的:探讨纳米羟基磷灰石/壳聚糖/半水硫酸钙作为注射型骨组织工程支架材料的可行性。方法:将第3代兔骨髓间充质干细胞与可注射纳米羟基磷灰石/壳聚糖/半水硫酸钙支架复合培养,作为实验组;以单纯接种培养的骨髓间充质干细胞为对照组,倒置显微镜下观察细胞生长情况,MTT法检测细胞增殖,扫描电镜观察细胞在材料表面生长与增殖。将纳米羟基磷灰石/壳聚糖/半水硫酸钙支架埋植在家兔背部肌袋内,埋植后2,4,6,8周进行病理学观察。结果与结论:实验组细胞生长、增殖良好,与对照组无明显差异。支架埋植后2周,材料周围有中等量中性粒细胞、淋巴细胞和巨细胞浸润,可见小血管与纤维母细胞增生,材料已被炎性细胞分割、围绕散碎;埋植后4周,可见少量淋巴细胞、纤维母细胞聚集,炎症反应进一步消退,肌纤维排列、形态正常;埋植后6周,材料周围炎症反应轻微,组织水肿不明显;埋植后8周,炎症反应基本消退,材料基本降解完成,肌纤维形态基本正常。表明纳米羟基磷灰石/壳聚糖/半水硫酸钙复合物具有良好的细胞相容性和生物降解性,可作为注射型支架材料。中国组织工程研究杂志出版内容重点:生物材料;骨生物材料; 口腔生物材料; 纳米材料; 缓释材料; 材料相容性;组织工程全文链接: 相似文献
11.
Tanaka T Hirose M Kotobuki N Tadokoro M Ohgushi H Fukuchi T Sato J Seto K 《Journal of biomedical materials research. Part A》2009,91(2):428-435
Poly-lactic-glycolic acid (PLGA) is a biocompatible as well as biodegradable polymer and used in various medical applications. In this study, we evaluated efficiency of the specially designed three-dimensional porous PLGA as a scaffold for bone augmentation. First, cell attachment/proliferation, differentiation, and mineralization of Fisher 344 rat marrow mesenchymal stem cells (MSCs) cultured on the PLGA scaffold were analyzed. Viable MSCs were impregnated into pore areas of the scaffold and a moderate increase of DNA contents was seen. High alkaline phosphatase, osteocalcin content, and calcium content of MSCs in PLGA scaffolds under osteogenic differentiation conditions were seen after 14 or 21 days of culture. Subsequently, we implanted the PLGA/MSCs composites on rat calvaria bone for 30 days. Newly formed bone was seen in only the composite PLGA/MSCs implantation group, which had been precultured under osteogenic condition. We also demonstrated that the newly formed bone originated from the donor composites. These results demonstrate that the three-dimensional PLGA scaffold can support osteogenic differentiation of MSCs, and the scaffold combined with osteogenic MSCs can be used for in vivo bone tissue augmentation. 相似文献
12.
Poly(lactic-co-glycolic acid) (PLGA)/collagen nanofibrous scaffolds have been utilized in the tissue engineering field. It has been shown that both fibronectin (FN) and cadherin 11 (CDH) play important roles in the progress of osteogenesis and cell adhesion. The aim of this study was to fabricate recombinant FN/CDHs (rFN/CDHs)-loaded PLGA/collagen nanofibrous scaffolds and evaluate their effects on the adhesion and differentiation of human bone marrow mesenchymal stem cells (hMSCs). PLGA/collagen nanofibers were made by coaxial electrospinning. The morphology and mechanical properties of PLGA/collagen nanofibrous mats were analyzed by scanning electron microscopy and mechanical testing, respectively. The performance of scaffolds was evaluated in terms of the viability, morphology, and osteogenic gene expression levels of hMSCs. rFN/CDHs was successfully incorporated into the PLGA/collagen nanofibers. The release of rFN/CDHs from PLGA nanofibers was investigated by liquid chromatography–mass spectrometry. rFN/CDHs improved the mechanical properties of the PLGA/collagen nanofibers. The controlled release of rFN/CDHs can enhance the proliferation of hMSCs and induce osteogenic gene expression (alkaline phosphatase, RUNX2, and osteocalcin). Our data imply that rFN/CDHs may induce hMSCs differentiation into osteoblasts and PLGA/collagen nanofibers loaded with rFN/CDHs have potential in bone tissue engineering. 相似文献
13.
B. N. Singh 《Journal of biomaterials science. Polymer edition》2013,24(16):2011-2034
AbstractThe development of bone tissue construct through tissue engineering approach offers a great promise in meeting the increasing demand for repair and regeneration of damaged and/or diseased bone tissue. For the generation of bone tissue engineered construct, polymer-ceramic composite matrices with nanostructure architecture and mesenchymal stem cells (hMSCs) of human origin are of prime requirement. Keeping these in view, in the present work a novel electrospun nanofibrous silk fibroin (SF)/carboxymethyl cellulose (CMC)/nano-bioglass (nBG) composite scaffold that mimics native bone extracellular matrix with appropriate composition was designed and fabricated by free liquid surface electrospinning technique. The scaffold possesses desired morphological, structural, biodegradability, bioactivity, surface roughness and mechanical properties thereby exhibited an excellent platform to support the growth of cells. The in-vitro culture of hMSCs over the developed scaffold has shown adhesion, proliferation and viability of cells, thus facilitated cell-scaffold construct generation and further extracellular bone matrix formation through osteogenic differentiation as evident from alkaline phosphatase activity, biomineralization, immunostaining and Runx2/osteocalcin expression assessment. Thus, the developed hMSCs seeded scaffold construct might be suitable for bone tissue engineering applications. 相似文献
14.
Li D Ye C Zhu Y Gou Z Gao C 《Journal of biomedical materials research. Part B, Applied biomaterials》2012,100(4):1103-1113
The bone mesenchymal stem cells (BMSCs) were seeded on [poly(lactide-co-glycolide) scaffolds with hydroxyapatite (HA) coating, and "s" stands for surface] (PLGA/HA-S), PLGA/HA-M (containing the same HA amount in the matrix as that of the PLGA/HA-S and "m" stands for matrix), and PLGA scaffolds, which were then cultured in a medium-containing Escherichia coli-derived recombinant human bone morphogenetic protein-2 (ErhBMP-2). In vitro culture of rat BMSCs found no different cell morphology in all the scaffolds, but the alkaline phosphatase activity and osteogenic gene expression of type I collagen (COL I) and osteocalcin (OCN) in the PLGA/HA-S scaffolds were always highest and were significantly improved in comparison with those in the PLGA scaffolds. In a rat calvarial defect model, new bone formation was enhanced in the PLGA/HA-S/ErhBMP-2 implants at 4 and 8 weeks after implantation too. Therefore, the PLGA/HA-S scaffold can better enhance the ErhBMP-2-induced osteogenic differentiation of BMSCs in vitro and osteogenesis in vivo. 相似文献
15.
背景:组织工程骨成骨功能终末细胞需要骨髓间充质干细胞在体外加以诱导或在体内以基因转染等技术加以诱导。
目的:研究Ⅰ型胶原修饰的聚乳酸聚乙醇酸微球支架上骨髓间充质干细胞黏附和成骨分化的能力。
方法:制备聚乳酸聚乙醇酸微球支架,分离纯化雌性SD大鼠骨髓间充质干细胞。将培养至第3代骨髓间充质干细胞与未经处理的聚乳酸聚乙醇酸微球及Ⅰ型胶原修饰的聚乳酸聚乙醇酸微球共同培养14 d,观察细胞在不同支架表面的黏附生长。
结果:扫描电镜及FDA-PI染色发现,骨髓间充质干细胞可在聚乳酸聚乙醇酸微球支架上生长,而与未修饰的聚乳酸聚乙醇酸微球相比骨髓间充质干细胞更容易在Ⅰ型胶原修饰的聚乳酸聚乙醇酸微球上黏附增殖。Ⅰ型胶原修饰的聚乳酸聚乙醇酸微球有利于骨髓间充质干细胞的黏附、增殖,并且有一定诱导干细胞成骨分化的能力。 相似文献
16.
《Journal of biomaterials science. Polymer edition》2013,24(8-9):1227-1238
In vitro osteogenesis was successfully achieved with synovium-derived mesenchymal stem cells (SMSCs), which intrinsically have a strong chondrogenic tendency, by in situ release of alendronate (AL) and dexamethasone (Dex) from poly(lactic-co-glycolic acid) (PLGA)/hydroxyapatite (HA) sintered microspherical scaffold (PLGA/HA-SMS). Cumulative release profiles of AL and Dex from PLGA/HA-SMS and the influence on SMSCs osteogenic commitment were investigated. SMSCs seeded in Al-/Dex-loaded PLGA/HA-SMS (PLGA/HA-Com-SMS) exhibited significant osteogenic differentiation, as indicated by high yields of alkaline phosphatase (ALP) and bone calcification. In addition, mechanical properties (compressional) of PLGA/HA-Com-SMSs were also evaluated and approved. In conclusion, by promoting osteogenic commitment of SMSCs in vitro, this newly designed controlled-release system opens a new door to bone reparation and regeneration. 相似文献
17.
Enhancement of the in vivo osteogenic potential of marrow/hydroxyapatite composites by bovine bone morphogenetic protein 总被引:5,自引:0,他引:5
Noshi T Yoshikawa T Ikeuchi M Dohi Y Ohgushi H Horiuchi K Sugimura M Ichijima K Yonemasu K 《Journal of biomedical materials research》2000,52(4):621-630
A composite of marrow mesenchymal stem cells and porous hydroxyapatite (HA) has in vivo osteogenic potential. To investigate factors enhancing the osteogenic potential of marrow/HA composites, we prepared a bone morphogenetic protein (BMP) fraction from the 4M guanidine extract of bovine bone by heparin-sepharose affinity chromatography. Marrow/HA composites or composites containing marrow mesenchymal stem cells, BMP, and HA (marrow/BMP/HA composites) were implanted subcutaneously in 7-week-old male Fischer rats. BMP/HA composites and HA alone were also implanted. The implants were harvested after 2, 4, or 8 weeks and were prepared for histological and biochemical studies. Histological examination showed obvious de novo bone formation together with active osteoblasts at 2 weeks, as well as more extensive bone formation at 4 and 8 weeks in many pores of the marrow/BMP/HA composites. The marrow/HA composites did not induce bone formation at 2 weeks, but there was moderate bone formation at 4 weeks. At 2 weeks, only marrow/BMP/HA composites resulted in intensive osteogenic activity, judging from alkaline phosphatase and osteocalcin expression at both the protein and gene levels. These results indicate that the combination of marrow mesenchymal stem cells, porous HA, and BMP synergistically enhances osteogenic potential, and may provide a rational basis for their clinical application, although further in vivo experiment is needed. 相似文献
18.
背景:骨髓间充质干细胞发挥成骨作用需要支架材料的辅助,一方面支架材料不仅可将细胞运载至骨缺损区域,另一方面还可作为新骨生长的框架结构。胶原-壳聚糖复合材料是骨组织工程较为理想的支架材料之一,同时其具有骨诱导性,比常规支架材料更优越的成骨能力。骨搬移技术在临床上在修复长段骨缺损方面已得到广泛应用,但也存在成骨慢、外固定时间长、骨不连等缺憾。如何进一步加快骨形成速度,减少并发症发生,已成当前亟待解决的问题。实验假设:骨髓间充质干细胞复合胶原-壳聚糖支架移植能提高胫骨缺损骨搬移修复效果。
方法/设计:随机对照动物实验。分为体外和体内实验两部分。体外实验中取月龄一两个月的新西兰大白兔股骨骨髓,提取骨髓间充质干细胞,培养至第3代,将细胞悬液滴于胶原-壳聚糖支架材料,构建骨髓间充质干细胞复合胶原-壳聚糖支架。体内实验选用24只三四月龄新西兰大白兔,被随机分配接受如下干预:骨搬移、支架植入、骨搬移联合支架植入。研究的主要观察指标为植入材料与骨缺损界面的生长情况、X射线检测的缺损区骨修复情况、苏木精-伊红染色及扫描电镜观察缺损区成骨情况、免疫组织化学染色检测成骨区Ⅰ型胶原蛋白的表达情况、扫描电子显微镜观察移植材料与宿主骨的界面键合情况、超微结构及新骨的生成。
讨论:实验结果将有助于确定对骨缺损进行骨搬移治疗过程中,应用骨髓间充质干细胞复合胶原-壳聚糖支架移植促进骨缺损再生修复效果的可行性。
实验方案获基金支持情况:获辽宁省科学技术计划项目资助(2012225019)。
中国组织工程研究杂志出版内容重点:干细胞;骨髓干细胞;造血干细胞;脂肪干细胞;肿瘤干细胞;胚胎干细胞;脐带脐血干细胞;干细胞诱导;干细胞分化;组织工程 相似文献
19.
Accelerated bonelike apatite growth on porous polymer/ceramic composite scaffolds in vitro 总被引:8,自引:0,他引:8
Although biodegradable polymer/ceramic composite scaffolds can overcome the limitations of conventional ceramic bone substitutes, the osteogenic potential of these scaffolds needs to be further enhanced for efficient bone tissue engineering. In this study, bonelike apatite was efficiently coated onto the scaffold surface by using polymer/ceramic composite scaffolds instead of polymer scaffolds and by using an accelerated biomimetic process to enhance the osteogenic potential of the scaffold. The creation of bonelike, apatite-coated polymer scaffold was achieved by incubating the scaffolds in simulated body fluid (SBF). The apatite growth on porous poly(D,L-lactic-co-glycolic acid)/nanohydroxyapatite (PLGA/ HA) composite scaffolds was significantly faster than on porous PLGA scaffolds. In addition, the distribution of coated apatite was more uniform on PLGA/HA scaffolds than on PLGA scaffolds. After a 5-day incubation period, the mass of apatite coated onto PLGA/HA scaffolds incubated in 5 x SBF was 2.3-fold higher than PLGA/HA scaffolds incubated in 1 x SBF. Furthermore, when the scaffolds were incubated in 5 x SBF for 5 days, the mass of apatite coated onto PLGA/HA scaffolds was 4.5-fold higher than PLGA scaffolds. These results indicate that the biomimetic apatite coating can be accelerated by using a polymer/ceramic composite scaffold and concentrated SBF. When seeded with osteoblasts, the apatite-coated PLGA/HA scaffolds exhibited significantly higher cell growth, alkaline phosphatase activity, and mineralization in vitro compared to the apatite-coated PLGA scaffolds. Therefore, the apatite-coated PLGA/HA scaffolds may provide enhanced osteogenic potential when used as scaffold for bone tissue engineering. 相似文献
20.
A number of studies have shown in vivo bone regeneration by transplantation of osteogenic cells differentiated in vitro from adipose-derived stromal cells (ADSCs). However, the in vitro osteogenic differentiation process requires an additional culture period, and the dexamethasone that is generally used in the process may be cytotoxic. Here, we tested the hypothesis that ADSCs that are not differentiated osteogenically in vitro prior to transplantation would extensively regenerate bone in vivo when exogenous bone morphogenetic protein-2 (BMP-2) is delivered to the transplantation site. We fabricated a poly(dl-lactic-co-glycolic acid)/hydroxyapatite (PLGA/HA) composite scaffold with osteoactive HA that is highly exposed on the scaffold surface. This scaffold was able to release BMP-2 over a 4-week period in vitro. Human ADSCs cultured on BMP-2-loaded PLGA/HA scaffolds for 2 weeks differentiated toward osteogenic cells expressing alkaline phosphatase (ALP), osteopontin (OPN), and osteocalcin (OCN) mRNA, while cells on PLGA/HA scaffolds without BMP-2 expressed only ALP. To study in vivo bone formation, PLGA/HA scaffolds (group 1), BMP-2-loaded PLGA/HA scaffolds (group 2), undifferentiated ADSCs seeded on PLGA/HA scaffolds (group 3), and undifferentiated ADSCs seeded on BMP-2-loaded PLGA/HA scaffolds (group 4) were implanted into dorsal, subcutaneous spaces of athymic mice. Eight weeks after implantation, group 4 exhibited a 25-fold greater bone formation area and 5-fold higher calcium deposition than group 3. Bone regeneration by transplanted human ADSCs in group 4 was confirmed by expression of human-specific osteoblastic genes, ALP, collagen type I, OPN, OCN, and bone sialoprotein, while group 3 expressed much lower levels of collagen type I and OPN mRNA only. This study demonstrates the feasibility of extensive in vivo bone regeneration by transplantation of ADSCs without prior in vitro osteogenic differentiation, and that a PLGA/HA composite BMP-2 delivery system stimulates bone regeneration following transplantation of undifferentiated human ADSCs. 相似文献